tm logo
HIFROCZI
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 23 Oct 2023

Last Applicant/ Owned by

Astraallén

Södertälje

SE

SE-15185

Serial Number

88665592 filed on 23rd Oct 2019

Registration Number

N/A

Correspondent Address

Cara M. Kearney

AstraZeneca Pharmaceuticals LP

1800 Concord Pike, A2C

Wilmington DE 19850-5437

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

HIFROCZI

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Mark Details


Serial Number

No 88665592

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
23rd Oct 2023ABANDONMENT - NO USE STATEMENT FILED
23rd Oct 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
30th Mar 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29th Mar 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
29th Mar 2023SOU EXTENSION 5 GRANTED
17th Mar 2023SOU TEAS EXTENSION RECEIVED
17th Mar 2023SOU EXTENSION 5 FILED
14th Sep 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12th Sep 2022SOU TEAS EXTENSION RECEIVED
12th Sep 2022SOU EXTENSION 4 FILED